On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The new online Learning Center with new content can still be found under the “Training” folder on ...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...